Design of granulatimide and isogranulatimide analogues as potential Chk1 inhibitors: Study of amino-platforms for their synthesis

Bioorganic & Medicinal Chemistry
2014.0

Abstract

The two marine alkaloids granulatimide and isogranulatimide have been shown to inhibit the checkpoint kinase 1 (Chk1), a promising target for cancer treatment. A molecular docking study allowing the design of new potential Chk1 inhibitors based on the natural products skeleton and the synthetic work to an amino-target platform to prepare them are described.

Knowledge Graph

Similar Paper

Design of granulatimide and isogranulatimide analogues as potential Chk1 inhibitors: Study of amino-platforms for their synthesis
Bioorganic & Medicinal Chemistry 2014.0
Synthesis and biological activities of isogranulatimide analogues
Bioorganic & Medicinal Chemistry 2007.0
Synthesis and Biological Activities of New Checkpoint Kinase 1 Inhibitors Structurally Related to Granulatimide
Journal of Medicinal Chemistry 2007.0
Synthesis and evaluation of debromohymenialdisine-derived Chk2 inhibitors
Bioorganic & Medicinal Chemistry 2012.0
Synthesis and biological evaluation of analogs of the marine alkaloids granulatimide and isogranulatimide
European Journal of Medicinal Chemistry 2012.0
Granulatimide and Isogranulatimide, Aromatic Alkaloids with G2 Checkpoint Inhibition Activity Isolated from the Brazilian Ascidian Didemnum granulatum:  Structure Elucidation and Synthesis
The Journal of Organic Chemistry 1998.0
Granulatimide and Isogranulatimide, Aromatic Alkaloids with G2 Checkpoint Inhibition Activity Isolated from the Brazilian Ascidian <i>Didemnum </i><i>granulatum</i>:  Structure Elucidation and Synthesis
The Journal of Organic Chemistry 1998.0
Discovery of 3-Alkoxyamino-5-(pyridin-2-ylamino)pyrazine-2-carbonitriles as Selective, Orally Bioavailable CHK1 Inhibitors
Journal of Medicinal Chemistry 2012.0
Structure-Based Design of (5-Arylamino-2H-pyrazol-3-yl)-biphenyl-2‘,4‘-diols as Novel and Potent Human CHK1 Inhibitors
Journal of Medicinal Chemistry 2007.0
RETRACTED: Identification of novel aminothiazole and aminothiadiazole conjugated cyanopyridines as selective CHK1 inhibitors
European Journal of Medicinal Chemistry 2015.0